HEMALATHA, G.M. et al. 2022. ISONIAZID-BASED SCHIFF’S BASES IN BONE CANCER STUDIES USING MG-63 CELL LINES. International Journal of Applied Pharmaceutics. 14, (Jul. 2022), 168–174. DOI:https://doi.org/10.22159/ijap.2022.v14ti.48.